Although acute leukemias are typically highly proliferative, the effect of one-carbon folate pathway inhibition using a novel inhibitor of SHMT1 and SHMT2, RZ-2994, was greater in T-ALL compared to AML. The gene discussed is SHMT2; the disease is acute lymphoblastic leukemia.